Applied DNA Sciences Revenue, Profits - APDN Quarterly Income Statement

Add to My Stocks
$1.14 $0.01 (0.87%) APDN stock closing price Sep 17, 2018 (Closing)

Financial statements provide us with a way to gain insights and undertake the fundamental analysis of a company. Checking Applied DNA Sciences stock price alone is not sufficient. An income statement is one of the three key financial statements furnished by a company, the other two being the balance sheet and the cashflow statement. When compared with the corresponding income statement from the past, the latest income statement shows how revenue has decreased from 1.04M to 1.02M and how operating and non operating activities have impacted the APDN stock. The Applied DNA Sciences profit and loss statement for 2018 Q3 shows a net profit of $-2.89M. Profits for last year was $-2.15M. Apart from this an investor should also check Applied DNA Sciences assets and Applied DNA Sciences free cash flow.

View and download details of revenue and profits for Applied DNA Sciences for latest & last 40 quarters.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Oct - Sep2018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q2
Applied DNA Sciences Revenues or Net Sales
1.02M1.04M-1.15M1.8M--1.64M--
Cost Of Goods Sold (COGS)----------
Applied DNA Sciences Gross Profit
----1.56M--1.01M--
Research & Development Expense-------1.43M1.07M-
Selling General & Admin Expense2.88M1.99M2.59M2.79M3.4M3.23M3.9M1.86M2.7M3.12M
Income Before Depreciation Depletion Amortization-2.74M-1.99M-3.01M-2.45M-2.44M-3.25M-3.79M-2.27M-3.25M-3.27M
Depreciation Depletion Amortization----------
Non Operating Income-0.02M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M---0.02M
Interest Expense----------
Applied DNA Sciences Pretax Income
-2.89M-2.14M-3.18M-2.86M-2.61M-3.42M-3.96M-2.43M-3.36M-3.46M
Provision for Income Taxes----------
MinorityInterest----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-2.89M-2.15M-3.18M-2.86M-2.61M-3.43M-3.96M-2.42M-3.37M-3.47M
Extraordinary Items & Discontinued Operations----------
Applied DNA Sciences Profit/ Loss (Net Income)
-2.89M-2.15M-3.18M-2.86M-2.61M-3.43M-3.96M-2.42M-3.37M-3.47M
Average Shares used to compute Diluted EPS30.11M30M27.67M27.38M26.37M26.35M25.43M24.08M24.08M24.07M
Average Shares used to compute Basic EPS30.11M30.11M27.67M27.38M26.37M26.35M25.43M24.08M24.08M24.07M
Income Before Nonrecurring Items-2.89M-2.15M-3.18M-2.86M-2.61M-3.43M-3.96M-2.42M-3.37M-3.47M
Income from Nonrecurring Items----------
Applied DNA Sciences Earnings Per Share Basic Net
-0.10-0.07-0.12-0.10-0.10-0.13-0.16-0.10-0.14-0.14
Applied DNA Sciences Earnings Per Share Diluted Net
-0.10-0.07-0.12-0.10-0.10-0.13-0.16-0.10-0.14-0.14
EPS Diluted Before Nonrecurring Items-0.10-0.07-0.12-0.10-0.10-0.13-0.16-0.10-0.14-0.14
Preferred Dividends Acc Pd----------
Dividends Common0.000.000.00-------
Dividend Per Share Common0.000.000.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

The key things to look for in an income statement while doing Applied DNA Sciences stock analysis are:

  • Revenue: This is the inflow that is generated from the sale of goods or services and is $1.02M for this quarter of 2018 Q3. Our Applied DNA Sciences revenue chart gives a clear visual representation of how the topline or sales growth has been. Investors often invest only in those companies where the revenue is growing at a steady rate.
  • Bottom line: The bottomline or the net income figure is arrived at by deducting all expenses from the topline which in this case is $-2.89M for APDN stock. An improving bottomline implies that the company is growing its profits.

The income statement is also called statement of revenue and expense. The APDN financials along with Applied DNA Sciences historical stock prices provide a lot of details about the firm.

Applied DNA Sciences Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
8.89
Dividend Yield
0%